Search - tctmd.com

Displaying 221 - 240 of 281

Sort: Relevancy | Date

Presentation TCT 2015

Spain Presents: A Case of iFR-FFR to Guide Coronary Revascularization in Multivessel Disease

Presenter: Morton J. Kern, Jan J. Piek, Javier Escaned

October 12, 2015

Presentation TCT 2015

The United Kingdom Presents: A Case of iFR for Evaluation of Serial Stenosis Using Pullback

Presenter: Morton J. Kern, Jan J. Piek, Justin E. Davies

October 12, 2015

Presentation TCT 2015

How to Assess the Quality of Evidence From Peer-Reviewed Manuscripts: The Statistical Reviewers Vantage Point

Presenter: Robert A. Harrington, Pascal Vranckx, Jan Tijssen

October 11, 2015

Presentation TCT 2015

Bayesian Statistics: Can They Be Trusted (or Understood)?!

Presenter: Stuart J. Pocock, Jan Tijssen, Sanjay Kaul

October 11, 2015

Presentation TCT 2015

Meta-analysis (Standard and Network): The Good, the Bad, and the Ugly

Presenter: Stuart J. Pocock, Jan Tijssen, Somjot S. Brar

October 11, 2015

Presentation TCT 2015

Composite Endpoints/Primary Endpoints/Weighted Endpoints/Patient-Reported Endpoints: How to Choose the Right Endpoint

Presenter: Stuart J. Pocock, Jan Tijssen

October 11, 2015

Presentation TCT 2015

Strategy Trials vs Device/Drug Comparisons: Important Considerations

Presenter: Stuart J. Pocock, Jan Tijssen, David J. Cohen

October 11, 2015

Presentation TCT 2015

Propensity-Matched Analysis: Advantages and Pitfalls (TRANSLATE and PROMETHEUS)

Presenter: Stuart J. Pocock, Jan Tijssen, Usman Baber

October 11, 2015

Presentation TCT 2015

Subgroup Analyses: How Useful or Harmful Are They?

Presenter: Stuart J. Pocock, Jan Tijssen, Darrel P. Francis

October 11, 2015

Presentation TCT 2015

Observational vs Randomized Trials: Strengths and Weaknesses (With Case Examples)

Presenter: Stuart J. Pocock, Jan Tijssen, John L. Petersen

October 11, 2015

Presentation BRS 2015

A Complex STEMI

Presenter: Robert-Jan van Geuns

February 10, 2015

Presentation

Anticoagulant Therapy and Outcomes in Patients With Prior or Acute HF and ACS

Presenter: Jan H. Cornel

January 13, 2015

Presentation TCT 2014

Will Bioresorbable Scaffolds Change How We Think About Left Main PCI?

Presenter: Andrejs Erglis, Nicholas J. Lembo, Hadley K. Wilson, Robert-Jan van Geuns

September 16, 2014

Presentation TCT 2014

Absorb III/IV: Testing Noninferiority and Superiority

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns, Dean J. Kereiakes

September 16, 2014

Presentation TCT 2014

Absorb III/IV: Angina and Ischemia Hypotheses

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns, Gregg W. Stone

September 16, 2014

Presentation TCT 2014

Update: The EXTEND Real-World Registry

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns, Alexandre Abizaid

September 16, 2014

Presentation TCT 2014

Update: The Absorb ASSURE Real-World Registry

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns, Thomas Schmitz

September 16, 2014

Presentation TCT 2014

Update: The Absorb GHOST Real-World Registry

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns, Corrado Tamburino

September 16, 2014

Presentation TCT 2014

Update: The Absorb FIRST Real-World Registry

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns, Christoph K. Naber

September 16, 2014

Presentation TCT 2014

Update: The Absorb EXPAND Real-World Registry

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns

September 16, 2014

Advertisement

Spain Presents: A Case of iFR-FFR to Guide Coronary Revascularization in Multivessel Disease

The United Kingdom Presents: A Case of iFR for Evaluation of Serial Stenosis Using Pullback

How to Assess the Quality of Evidence From Peer-Reviewed Manuscripts: The Statistical Reviewers Vantage Point

Bayesian Statistics: Can They Be Trusted (or Understood)?!

Meta-analysis (Standard and Network): The Good, the Bad, and the Ugly

Composite Endpoints/Primary Endpoints/Weighted Endpoints/Patient-Reported Endpoints: How to Choose the Right Endpoint

Strategy Trials vs Device/Drug Comparisons: Important Considerations

Propensity-Matched Analysis: Advantages and Pitfalls (TRANSLATE and PROMETHEUS)

Subgroup Analyses: How Useful or Harmful Are They?

Observational vs Randomized Trials: Strengths and Weaknesses (With Case Examples)

A Complex STEMI

Anticoagulant Therapy and Outcomes in Patients With Prior or Acute HF and ACS

Will Bioresorbable Scaffolds Change How We Think About Left Main PCI?

Absorb III/IV: Testing Noninferiority and Superiority

Absorb III/IV: Angina and Ischemia Hypotheses

Update: The EXTEND Real-World Registry

Update: The Absorb ASSURE Real-World Registry

Update: The Absorb GHOST Real-World Registry

Update: The Absorb FIRST Real-World Registry

Update: The Absorb EXPAND Real-World Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content